体外成熟、体外受精与卵胞浆内单精子注射后子代生理:动物研究的系统综述与Meta分析
该系统综述与Meta分析检索截至2021年8月27日的PubMed、Embase和CAB Abstracts,纳入61项比较体外受精、卵胞浆内单精子注射或体外成熟与体内受精哺乳动物子代出生后结局的研究,涉及牛、马、小鼠、绵羊和非人灵长类五种物种。研究提示体外受精或体外成熟可能导致子代出生体重更高、妊娠期更长,多数证据来自牛的研究,这些技术还可能损害雄性小鼠的糖脂代谢,但心血管和行为结局在各研究间不一致。
要点
- 体外受精或体外成熟可能使子代出生体重更高、妊娠期更长,多数证据来自牛的研究。
- 这些技术还可能损害雄性小鼠的糖脂代谢。
- 心血管结局和行为结局在各研究间不一致,异质性较大,难以得出确定结论。
核心结论
- 体外或体内受孕方式似乎影响子代生理的可测量结局,且在不同研究物种中表现不同。
- 这些可测量的差异在健康、生育力正常的动物群体中即可观察到。
- 由于方法、结果和测量结局异质性大,难以得出确定结论。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase和CAB Abstracts截至2021年8月27日发表的文献。
- 纳入比较体外受孕(体外受精、卵胞浆内单精子注射或体外成熟)与体内受孕哺乳动物模型子代出生后结局的研究。
- 共纳入61项研究,涉及牛、马、小鼠、绵羊和非人灵长类五种物种。
- 牛模型最常用于体外成熟研究(32/40),小鼠模型最常用于体外受精(17/20)和卵胞浆内单精子注射(6/8)研究。
主要发现
- 体外受精或体外成熟可能导致子代出生体重更高、妊娠期更长,多数证据来自牛的研究。
- 这些技术还可能损害雄性小鼠的葡萄糖和脂质代谢。
- 心血管结局和行为结局在各研究间不一致。
临床怎么用
- 作者认为,常见辅助生殖技术干预可能对通过这些技术受孕的子代产生长期影响,无论不孕诊断的病理基础如何。
- 作者认为,优化研究新生殖技术安全性的动物和人类研究将有助于保障新干预措施安全引入临床。
- 作者认为,可考虑在临床谨慎使用辅助生殖技术,以减少在长期安全性被充分记录之前受孕儿童出现不良结局的机会。
局限性
- 研究间存在相当大的异质性。
- 由于方法、结果和测量结局异质性大,难以得出确定结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since the birth of the first baby using IVF technology in 1978, over 10 million children have been conceived via ART. Although most aspects of ARTs were developed in animal models, the introduction of these technologies into clinical practice was performed without comprehensive assessment of their long-term safety. The monitoring of these technologies over time has revealed differences in the physiology of babies produced using ARTs, yet due to the pathology of those presenting for treatment, it is challenging to separate the cause of infertility from the effect of treatments offered. The use of systematic review and meta-analysis to investigate the impacts of the predominant ART interventions used clinically in human populations on animals produced in healthy fertile populations offers an alternative approach to understanding the long-term safety of reproductive technologies. OBJECTIVE AND RATIONALE: This systematic review and meta-analysis aimed to examine the evidence available from animal studies on physiological outcomes in the offspring conceived after IVF, IVM or ICSI, compared to in vivo fertilization, and to provide an overview on the landscape of research in this area. SEARCH METHODS: PubMed, Embase and Commonwealth Agricultural Bureaux (CAB) Abstracts were searched for relevant studies published until 27 August 2021. Search terms relating to assisted reproductive technology, postnatal outcomes and mammalian animal models were used. Studies that compared postnatal outcomes between in vitro-conceived (IVF, ICSI or IVM) and in vivo-conceived mammalian animal models were included. In vivo conception included mating, artificial insemination, or either of these followed by embryo transfer to a recipient animal with or without in vitro culture. Outcomes included birth weight, gestation length, cardiovascular, metabolic and behavioural characteristics and lifespan. OUTCOMES: A total of 61 studies in five different species (bovine, equine, murine, ovine and non-human primate) met the inclusion criteria. The bovine model was the most frequently used in IVM studies (32/40), while the murine model was mostly used in IVF (17/20) and ICSI (6/8) investigations. Despite considerable heterogeneity, these studies suggest that the use of IVF or maturation results in offspring with higher birthweights and a longer length of gestation, with most of this evidence coming from studies in cattle. These techniques may also impair glucose and lipid metabolism in male mice. The findings on cardiovascular outcomes and behaviour outcomes were inconsistent across studies. WIDER IMPLICATIONS: Conception via in vitro or in vivo means appears to have an influence on measurable outcomes of offspring physiology, manifesting differently across the species studied. Importantly, it can be noted that these measurable differences are noticeable in healthy, fertile animal populations. Thus, common ART interventions may have long-term consequences for those conceived through these techniques, regardless of the pathology underpinning diagnosed infertility. However, due to heterogeneous methods, results and measured outcomes, highlighted in this review, it is difficult to draw firm conclusions. Optimizing animal and human studies that investigate the safety of new reproductive technologies will provide insight into safeguarding the introduction of novel interventions into the clinical setting. Cautiously prescribing the use of ARTs clinically may also be considered to reduce the chance of promoting adverse outcomes in children conceived before long-term safety is confidently documented.
引用
- Beilby KH, Kneebone E, Roseboom TJ, et al. Offspring physiology following the use of IVM, IVF and ICSI: a systematic review and meta-analysis of animal studies. Hum Reprod Update. 2023. PMID: 36611003. doi:10.1093/humupd/dmac043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。